Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-06 @ 4:16 AM
Study NCT ID:
NCT06246968
Status:
RECRUITING
Last Update Posted:
2025-05-21
First Post:
2024-01-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
| None | Breast Cancer | View |
| None | Breast Cancer Stage IV | View |
| None | Triple Negative Breast Cancer | View |
| None | Triple Negative Breast Neoplasms | View |
| None | Metastatic Triple-Negative Breast Carcinoma | View |
| None | Locally Advanced Breast Cancer | View |
| None | Locally Advanced Triple-Negative Breast Carcinoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | metastatic TNBC | View |
| None | metastatic triple negative breast carcinoma | View |
| None | metastatic breast cancer | View |
| None | breast cancer | View |
| None | breast cancer stage IV | View |
| None | triple negative breast cancer | View |
| None | pembrolizumab | View |
| None | cryoablation | View |
| None | Memorial Sloan Kettering Cancer Center | View |
| None | 23-390 | View |
| None | locally advanced breast cancer | View |
| None | locally advanced triple negative breast carcinoma | View |
| None | locally advanced triple negative breast cancer | View |